SARCOMATOID CARCINOMA OF THE LUNG: A CLINICOPATHOLOGICAL STUDY INCLUDING EGFR AND KRAS MUTATION AND ALK PROTEIN EXPRESSION ANALYSIS

被引：0
|
作者：
Jia, X-L [1 ]
Chen, G. [1 ]
机构：
[1] Tongji Univ, Dept Pathol, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
来源：
RESPIROLOGY | 2011年 / 16卷
关键词：
Sarcomatoid carcinoma; EGFR mutation; KRAS mutation; ALK protein expression;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [21] Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
    Xuchao Zhang
    Shirley Zhang
    Xuening Yang
    Jinji Yang
    Qing Zhou
    Lucy Yin
    Shejuan An
    Jiaying Lin
    Shiliang Chen
    Zhi Xie
    Mike Zhu
    Xiaolin Zhang
    Yi-long Wu
    Molecular Cancer, 9
  • [22] Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
    Wu, Shafei
    Wang, Jinghui
    Zhou, Lijuan
    Su, Dan
    Liu, Yuanyuan
    Liang, Xiaolong
    Zhang, Shucai
    Zeng, Xuan
    THORACIC CANCER, 2015, 6 (04) : 413 - 420
  • [23] Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma
    Politi, Anastasia
    Tsiamb, Evangelos
    Mastronikolis, Nicholas S.
    Peschos, Dimitrios
    Asproudis, Ioannis
    Kyrodimos, Efthymios
    Armata, Ilianna E.
    Chrysovergis, Aristeidis
    Asimakopoulos, Asimakis
    Papanikolaou, Vasileios S.
    Batistatou, Anna
    Ragos, Vasileios
    IN VIVO, 2019, 33 (03): : 815 - 819
  • [24] EGFR mutation and protein expression analysis in sinonasal inverted papilloma and squamous cell carcinoma
    Cabal, Virginia N.
    Menendez, Marta
    Potes-Ares, Sira
    Vivanco, Blanca
    Suarez-Fernandez, Laura
    Riobello, Cristina
    Garcia-Marin, Rocio
    Lopez, Fernando
    Luis Llorente, Jose
    Hermsen, Mario
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
    Lee, Taebum
    Lee, Boram
    Choi, Yoon-La
    Han, Joungho
    Ahn, Myung-Ju
    Um, Sang-Won
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2016, 50 (03) : 197 - 203
  • [26] 95 Cases of EGFR/ALK Gene Status Analysis in Lung Adenosquamous Carcinoma
    Xu, Z.
    Xu, C.
    Wang, W.
    Xu, Q.
    Zhuang, W.
    Song, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2262 - S2262
  • [27] Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma
    Lococo, Filippo
    Gandolfi, Greta
    Rossi, Giulio
    Pinto, Carmine
    Rapicetta, Cristian
    Cavazza, Alberto
    Cesario, Alfredo
    Galeone, Carla
    Paci, Massimitiano
    Ciarrocchi, Alessia
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : 1282 - 1292
  • [28] EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC):: Results of a prospective phase II trial.
    Miller, V. A.
    Zakowski, M.
    Riely, G. J.
    Pao, W.
    Ladanyi, M.
    Tsao, A. S.
    Sandler, A.
    Herbst, R.
    Kris, M. G.
    Johnson, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 364S - 364S
  • [29] The Treatment of Colorectal Carcinoma With Monoclonal Antibodies The Importance of KRAS Mutation Analysis and EGFR Status
    Stintzing, Sebastian
    Heinemann, Volker
    Jung, Andreas
    Moosmann, Nicolas
    Hiddemann, Wolfgang
    Kirchner, Thomas
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (12): : 202 - 206
  • [30] CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer
    Lian, Weisheng
    Ouyang, Yong
    ONCOLOGY LETTERS, 2017, 13 (05) : 3415 - 3422
12345